Life Sciences Tools and Services
Company Overview of Aureon Biosciences, Inc.
Aureon Biosciences, Inc., a life sciences company, designs and develops prognostic tests. It enables the advancement of predictive and personalized cancer treatment options. The company’s prognostic tests include Prostate Px, which assists physicians as they counsel patients on the range of possible treatment options, as well as the patient’s probability of disease recurrence and disease progression; and Post-Op Px, a prognostic test to provide patients and their physicians with information about treatment options. Its prognostic tools provide risk assessment at diagnosis and after surgery. The company was founded in 2002 and is based in Yonkers, New York.
28 Wells Avenue
Yonkers, NY 10701
Founded in 2002
Key Executives for Aureon Biosciences, Inc.
Similar Private Companies By Industry
|MedTec, Inc.||United States|
|Clinical Development Group, LLC||United States|
|Capp Medical, Inc.||United States|
|Symbiance, Inc.||United States|
|Clontech Laboratories, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Aureon Biosciences, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.